Portland State University

PDXScholar
Dissertations and Theses

Dissertations and Theses

Spring 3-1-2016

Pharmaceutical Contaminants as Stressors on
Rocky Intertidal and Estuarine Organisms: a Case
Study of Fluoxetine
Joseph Richard Peters
Portland State University

Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds
Part of the Chemicals and Drugs Commons, Environmental Monitoring Commons, Marine Biology
Commons, and the Water Resource Management Commons

Let us know how access to this document benefits you.
Recommended Citation
Peters, Joseph Richard, "Pharmaceutical Contaminants as Stressors on Rocky Intertidal and Estuarine
Organisms: a Case Study of Fluoxetine" (2016). Dissertations and Theses. Paper 2729.
https://doi.org/10.15760/etd.2725

This Thesis is brought to you for free and open access. It has been accepted for inclusion in Dissertations and
Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more
accessible: pdxscholar@pdx.edu.

Pharmaceutical Contaminants as Stressors on Rocky Intertidal and Estuarine Organisms:
a Case Study of Fuoxetine

By
Joseph Richard Peters

A thesis submitted in partial fulfillment of the
requirements for the degree of

Master of Science
In
Environmental Science and Management

Thesis Committee:
Elise F. Granek, Chair
Angela L. Strecker
Catherine E. de Rivera

Portland State University
2016

ABSTRACT

Contaminants such as pharmaceuticals are of increasing concern due to their
ubiquitous use and persistence in surface waters worldwide. Limited attention has been
paid to the effects of pharmaceuticals on marine life, despite widespread detection of
these contaminants in the marine environment. Of the existing studies, the majority assess
the negative effects of pharmaceuticals over an exposure period of 30 days or less and
focus on cellular and subcellular biomarkers. Longer studies are required to determine if
chronic contaminant exposure poses risks to marine life at environmentally relevant
concentrations. Also scarce in the literature is examination of whole organism effects to
identify potential community-level consequences. Two long-term studies with the
antidepressant pharmaceutical, fluoxetine (the active constituent in Prozac®) were
conducted to determine whether nominal concentrations detected in estuarine and coastal
environments affect organism health and interactions.
First, we measured whole organism metrics in the California mussel, Mytilus
californianus over a period of 107 days. Specifically, we measured algal clearance rates,
growth, and condition indices for both reproductive and overall health. We found that
fluoxetine negatively affects all measured characteristics, however many effects are
mediated by length of exposure. Perhaps the most notable result was that mussels spiked
with fluoxetine cleared less algae after 30 days of exposure. Reduced growth and
i

condition indices likely are a consequence of improper nutrition among fluoxetine-treated
mussels. Any level of fluoxetine significantly affected the gonadosomatic index after 47
days. The results from this study on mussels fill an important data gap, highlighting
organism-level effects of chronic exposure periods; such data more explicitly identify the
impacts of pharmaceuticals and other contaminants on marine communities and
ecosystems.
Fluoxetine has also been documented to affect the behavior of fish and
invertebrates, including freshwater and marine bivalves, crustaceans, and fish. Given that
other crustaceans exhibited increased activity levels under fluoxetine exposure, we
hypothesized that this would subject them to greater predation risk. In our second
exposure study, we assessed whether a similar range of fluoxetine concentrations used in
the mussel study altered the risk behavior of the Oregon mud crab, Hemigrapsus
oregonensis, in response to a common predator, the red rock crab, Cancer productus. We
conducted this study for 60 days, conducting day and night behavioral trials (with and
without predators) four times a week. We found that crabs exposed to any amount of
fluoxetine (3 or 30 ng/L) had increased activity levels relative to controls; however
behaviors of 3 ng/L-spiked crabs were not always significantly different from controls.
Among control crabs, day and night trials yielded similar results, where a clear response
to the addition of the predator was observed. Crabs dosed with fluoxetine exhibited more
foraging and active behaviors in the presence of the predator. Additionally, crabs spiked
with fluoxetine at 30 ng/L had the greatest risk of mortality either by predation by red
ii

rock crabs or due to more aggressive behaviors among conspecifics. The results of this
study shed light on a particularly unexplored area of contaminants research: how do
psychoactive pharmaceuticals affect animal behavior when exposed to the low
concentrations persisting in the aquatic environment for a prolonged period of time?
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Chapter 1: Introduction

Whole suites of pharmaceuticals and their derivatives routinely enter the aquatic
realm through human wastewater effluent, septic systems, and animal waste runoff from
agricultural lands (Kolpin et al. 2002; Kinney et al. 2006; Ramirez et al. 2009). While
these drugs are often detected at very low concentrations (e.g., ng/L; Fent et al. 2006),
these compounds are designed to illicit cellular responses (e.g., enzymes, receptors) and
should not be regarded as trivial threats to aquatic organisms (Meredith-Williams et al.
2012; Franzellitti et al. 2014). Additionally, many pharmaceuticals are persistent in
aquatic environments, putting aquatic organisms at risk of chronic exposure and
bioaccumulation (Ramirez et al. 2009; Meredith-Williams et al. 2012). Numerous studies
have documented acute and chronic toxicities of countless pharmaceuticals on aquatic
organisms (Trudeau et al. 2005; Corcoran et al. 2010; Brausch et al. 2012); however
studies on coastal and marine organisms are lacking (Brooks et al. 2009; Brodin et al.
2014; Gaw et al. 2014). With large and growing human populations along coastlines,
much remains to be learned about the effects of pharmaceuticals on marine organisms to
better inform best management practices (Seiler et al. 2002; Valbonesi et al. 2003; Regoli
and Giuliani 2013).
Despite shared interests in pharmaceuticals as stressors to organisms and use of
the same species and similar endpoints, limited cross-citation suggests that the disciplines
of ecology and ecotoxicology are growing independently (Brodin et al. 2014). Most
1

ecotoxicological data are based on acute exposure periods of less than 24 hours with
recent studies running up to 30 days (Daugton and Ternes 1999; Brooks et al 2009; Gaw
et al. 2014). While useful for assessing how pharmaceuticals may alter cellular activities,
this approach is insufficient in length and scope to determine organism- or ecosystemlevel chronic effects. Ecologists are interested in how the presence of pharmaceuticals
may alter organism behavior (Hazleton et al. 2013; Chen et al. 2015), physiological
functioning (Fong 1998; Di et al. 2014), and ultimately how this may shift community
and ecosystem dynamics (Brodin et al. 2014; Hazleton et al. 2014). Short term (30 days
or less) chronic exposure studies allow for only limited inferences by ecologists about the
effects of pharmaceuticals on ecosystem processes. Long-term exposure studies with
concentrations that reflect those detected in the environment are required to answer most
ecological questions (Gaw et al. 2014, Brodin et al. 2014).
Estuarine and rocky intertidal organisms are particularly at risk from
pharmaceuticals as environmental stressors (Fong & Ford 2014), however data from
prolonged studies are lacking (Berninger & Brooks 2010; Gaw et al. 2014). Exposure to
heavy metals, pesticides, petroleum and other legacy contaminants have also been shown
to affect marine organisms by altering habitat preference, shifting migration patterns, or
increasing negative species interactions (Fleeger et al. 2003; Khoury et al. 2009; Eades &
Waring 2010; Fukunaga et al. 2010). Such alterations to normal behaviors have been
linked to reduced fitness, and changes to population structure and ecosystem function
(Frid & Dill 2002; Fahrig 2007; Ings et al. 2009). Experiments with pharmaceuticals can

2

be designed in a similar fashion by substituting the nominal concentrations of the drug or
its constituents as the stressor(s), and determining organism- or community-level
responses.
Selective serotonin reuptake inhibitor (SSRI) anti-depressants such as fluoxetine
hydrochloride (Prozac®) are among the more prevalent categories of pharmaceuticals
detected in the marine environment (Kreke and Dietrich 2008; Vasskog et al. 2008;
Brodin et al. 2014; Gaw et al. 2014). SSRIs have been developed to delay the reuptake of
serotonin, moderating neurotransmission in the human brain. However, serotonin,
serotonin analogs, and serotonin-altering drugs have been shown to dramatically affect
several marine species (see Fong & Ford 2014 for a recent review). Serotonin is an
important neuromodulater in bivalves, regulating gill cilliary activity, oocyte maturation,
and the induction of spawning (Gibbons and Castanga 1984). In crustaceans, serotonin is
well known to affect behaviors though stimulating the release of hyperglycaemic,
neurodepressing, moult-inhibiting, and gonad-stimulating hormones (Fong and Ford
2014).) Several other studies have demonstrated that fluoxetine leads to adverse
physiological and behavioral outcomes in aquatic organisms that could alter their
functional roles within the community (Perreault et al. 2003; Lynn et al. 2007; Stanley et
al. 2007; Mennigen et al. 2010; Schultz et al. 2011; Dzieweczynski & Herbert 2012;
Kohlert et al. 2012; Bossus et al. 2013; Barry 2013; Munari et al. 2014; Chen et al. 2015).
The objectives of the fluoxetine case study were to 1) assess whole-organism
metrics on the California mussel, Mytilus californianus during a long-term exposure
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experiment with environmentally relevant concentrations of fluoxetine detected in
nearshore marine environments (Chapter 2); and 2) determine if prolonged exposure to
similar fluoxetine concentrations affected activity levels, predation risk behavior, and
mortality in the Oregon shore crab, Hemigrapsus oregonensis with exposure to red rock
crabs, Cancer productus (Chapter 2). These two studies are critical steps towards
addressing how fluoxetine and other pharmaceutical contaminants may affect marine and
estuarine species in two very different ways. This work will help fill existing data gaps to
better inform best management practices and cradle-to-grave stewardship of
pharmaceutical drugs so they can be reduced or eliminated before entering the marine
environment.
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Chapter 2: Long-term exposure to fluoxetine reduces growth and reproductive potential
in the mussel, Mytilus californianus
Introduction
Pharmaceuticals are commonly detected in the aquatic environment (Daughton
and Ternes 1999; Ankley et al. 2007; Brausch and Rand 2011; Boxall et al. 2012). Due to
dilution, absorption, and physical breakdown, most pharmaceuticals are detected at very
low concentrations (e.g., ng/L; Fent et al. 2006). However as drugs, these compounds are
designed to illicit cellular responses (e.g., enzymes, receptors) and therefore their
nominal concentrations should not be regarded as trivial threats to aquatic organisms
(Meredith-Williams et al. 2012; Franzellitti et al. 2014). Because of their ubiquitous use,
many pharmaceuticals are persistent in aquatic environments, putting aquatic organisms
at risk of chronic exposure and bioaccumulation (Ramirez et al. 2009; Meredith-Williams
et al. 2012). Numerous studies have documented acute and chronic toxicities of countless
pharmaceuticals on aquatic organisms (Trudeau et al. 2005; Corcoran et al. 2010;
Brausch et al. 2012); however studies on coastal and marine organisms are fewer (Brooks
et al. 2009). With large human populations along coastlines much remains to be learned
about the effects of pharmaceuticals on marine organisms to better inform best
management practices (Seiler et al. 2002; Valbonesi et al. 2003; Regoli and Giuliani
2013).
There is debate over whether standard ecotoxicological methods are sufficient for
determining chronic exposure effects on organisms at environmentally relevant
5

concentrations (Corcoran et al. 2010; Franzellitti et al. 2014). Most ecotoxicological data
are based on acute exposure periods of less than 24 hours with recent studies running up
to 30 days (Daugton and Ternes 1999; Brooks et al 2009; Gaw et al. 2014). While useful
for assessing how pharmaceuticals may alter cellular activities, this approach is
insufficient in length and scope to determine organism- or ecosystem-level chronic
effects. Ecologists are interested in how the presence of pharmaceuticals may alter
organism behavior (Hazleton et al. 2013; Chen et al. 2015), physiological functioning
(Fong 1998; Di et al. 2014), and ultimately how this may shift community and ecosystem
dynamics (Hazleton et al. 2014). Depending on the life history of the organism (e.g., long
vs. short life span), short term (30 days or less) chronic exposure studies allow for only
limited inferences by ecologists about the effects of pharmaceuticals on ecosystem
processes. Long-term exposure studies with concentrations that reflect those detected in
the environment are required to answer most ecological questions for long-lived species.
Among the more prevalent categories of pharmaceuticals detected in the marine
environment are selective serotonin reuptake inhibitor (SSRI) anti-depressants such as
fluoxetine hydrochloride (Prozac®) (Kreke and Dietrich 2008; Vasskog et al. 2008).
These drugs have been developed to delay the reuptake of serotonin, moderating
neurotransmission in the human brain. However, serotonin is also an important
neuromodulater in bivalves, regulating gill cilliary activity, oocyte maturation, and the
induction of spawning (Gibbons and Castanga 1984; Fong and Ford 2014). Increased
serotonin levels in mussels via fluoxetine exposure have been shown to alter several
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important cellular activities that lead to reduced health status (Franzellitti et al. 2014;
Munari et al. 2014). Fong and Molnar (2008) found that norfluoxetine, the active
metabolite of fluoxetine, induced spawning and parturition in both estuarine and
freshwater bivalves at high concentrations (e.g. 29.5 mg/L). Several other studies have
demonstrated that fluoxetine leads to adverse physiological and behavioral outcomes in
marine invertebrates that could alter their functional roles within the community (Stanley
et al. 2007; Oakes et al. 2010; Bossus et al. 2013; Munari et al. 2014; Chen et al. 2015).
Bivalves such as mussels and oysters are at risk of chronic exposure to fluoxetine
particularly downstream from effluent-dominated coastal waterways (Brooks et al. 2005;
Brooks et al. 2006; Kwon and Armburst 2006; Kreke and Dietrich 2008). Oxidative
stress was observed in the marine mussel Mytilus galloprovincialis after 15 days of
exposure to fluoxetine at a concentration of only 75ng/L, a concentration detected in
surface waters (Gros et al. 2006; Metcalfe et al. 2003; Gonzalez-Rey and Bebianno
2013). Franzellitti et al. (2014) found that fluoxetine had adverse outcomes on cell
signaling and reduced the health status of the marine mussel M. galloprovincialis
following 7-day exposure to a range of concentrations detected in the marine
environment (e.g., 0.03-300 ng/L). But how do marine mussels react to this range of
fluoxetine concentrations over a longer exposure period (i.e., over 30 days) and in terms
of whole body metrics?
I designed a laboratory experiment to build on the findings of other marine
mussel- fluoxetine exposure studies where adverse effects among cellular biomarkers
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were identified at high concentrations for short time periods. I hypothesized that wholemussel metrics would be affected by four low, but environmentally-relevant, fluoxetine
concentrations over longer exposure periods. Specifically, I tested whether growth, body
and reproductive condition indices, and the rates of algae cleared by Mytilus
californianus mussels were affected by fluoxetine exposure over time. We measured
these variables at 47, 67, and 107 days of exposure. This study addresses two critical gaps
in emerging pharmaceutical contaminants research: 1) the impacts to whole organism
physiology and function; and 2) the effects of prolonged exposure periods.

Materials and methods
Experimental organisms and holding conditions
M. californianus mussels were collected from a single location on the jetty north
of Rockaway Beach, Oregon (45°39’18.4”N, 123°56’31.2”W) on August 1, 2014 and
transported in chilled seawater to the laboratory at Portland State University. Upon
arrival, mussels were measured and sorted into size classes. From these, 21 mussels were
randomly distributed into 25 housing tanks (~ 64 L each) with a mean total biomass of
87.13 ± 1.17 g per tank. Mean length and mass of individual mussels did not differ
among treatments (mean length = 32.22 ± SE (0.35) mm; one-way ANOVA, P = 0.1;
mean mass = 4.19 ± 0.13 g; P = 0.2) or tanks (one-way ANOVA, P > 0.7 in both cases;
See Appendix A for full summary of mussel metrics by treatment group).
Mussels were allowed to acclimate to laboratory conditions for one month before
the exposure study began. Each housing tank had an independent water chilling and
8

filtration system (Aquatic Enterprises). Seawater was prepared using Instant Ocean and
deionized water with salinity and temperature maintained at 35 PSU and 15 °C
respectively, to replicate conditions at the collection site. We monitored water chemistry
(i.e. ammonia, pH, nitrate, and nitrite) every two weeks to ensure levels were appropriate
for mussels. To reduce buildup of animal waste products, 20% of the seawater was
replaced with fresh seawater every 20 days. Tanks were dosed with fluoxetine following
water changes. Light cycle conditions were maintained at 10 h of dark and 14 h of
daylight. During the acclimation period, mussel health and condition were monitored. A
total of 4 mussels died during acclimation and were immediately replaced with one of the
extra mussels from the original collection. During the exposure study, there was no
mussel mortality.
Twice weekly, mussels were batch fed Shellfish Diet 1800® (Reed Mariculture)
diluted tenfold with seawater. The algae in the Shellfish Diet 1800® is a combination of
six marine microalgae Isochrysis, Pavlova, Tetraselmis, Chaetocerous calcitrans,
Thalassiosira weissflogii and Thalassiosira pseudonana with cell diameter sizes ranging
from 5 to 16 µm. Mussels were fed algae according to the total biomass in each tank. As
mussels were removed from the tanks for subsampling, algae diet was adjusted to the
total biomass in each tank (see Appendix A for total biomass of mussels per treatment
over the course of the study).
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Experimental design
We assigned 21 mussels to each tank representing one of five treatments of
fluoxetine ranging from 0 to 300 ng/L, which covers the range detected in the marine
environment (Franzellitti et al. 2014). Treatment groups were 0.3, 3, 30, and 300 ng/L of
fluoxetine and a control with no fluoxetine (Figure 2.1). Our experimental units were the
individual tanks (n=25) with 5 replicate tanks nested within each treatment group. Each
tank was subsampled on days 47, 67, and 107 with 6, 6, and 9 mussels sacrificed
respectively. With three sample periods the total number of observations was 75. A set
of 5 tanks with no mussels was used to determine a baseline for algae removed by the
tank filtration system during algal clearance trials. We note that one of the no-mussel
tanks malfunctioned after 20 days into the experiment and was excluded from further
analyses, reducing no-mussel tank replicates to 4.
Before each dosing period, fluoxetine solutions were prepared using a stock
solution of 1.0 mg/mL fluoxetine hydrochloride (Sigma-Aldrich) dissolved in nanopure
water. Each treatment concentration (0.3, 3.0, 30.0, and 300.0ng/L) was prepared using
separate dosing solutions, which were prepared through serial dilution of the original
stock solution. Every 10 days, the tanks were dosed by adding 193µL of the appropriate
fluoxetine dosing solution into each tank. Controls without fluoxetine received 193µL of
nanopure water on dosing days.

10

Figure 2.1 Schematic of aquarium set up, with the order of treatment tanks randomized.
Treatment groups included: Control, 0.3 ng L -1, 3.0 ng L -1, 3.0 ng L -1, 30 ng L -1, 300
ng L -1, No Mussel (NM) 3.0 ng L -1.

11

Fluoxetine exposure study
1. Algal clearance
On feeding days, a 10 mL seawater sample was obtained within 5 minute after the
algae mixture was added to each of the tanks to allow for thorough mixing. Mussels
were allowed to feed for 3 hours before an additional 10mL sample was extracted. These
samples served as initial and final concentrations, respectively. From each sample, we
counted algal cells in three 0.5 mL aliquots using a Beckman Coulter Counter (model Z1,
100 µm aperture) and determined the mean initial and final concentrations within each
tank. We collected a total of 11 samples over the course of the 107-day study.
Filtering rates were estimated from the rate of change in suspended particle
concentrations. Following Coughlan (1969), we based filtering rates on four assumptions:
a) the reduction in the concentration of particles is due to filtration by the animal, and to
settling, b) mussel pumping rate is constant, c) particle retention is 100% efficient and d)
there is homogenous suspension of particles. A set of identical tanks without mussels
(n=4) served as blanks for feeding trials. For each of the 11 sample dates, clearance rates
for each mussel were calculated using the following formula (Coughlin 1969):
CR= (M/n) [ln (C0/Ct)/t] – [ln (C0blank/Ctblank)/t]
where CR = clearance rate (cells-1mL-1min-1); M = volume of seawater in each tank (mL);
n = number of mussels in tank; t = feeding time (min); C0 = initial concentration of
particles in tank; Ct = final concentration of particles in tank. C0blank = initial
12

concentration of particles in tank without mussels; Ctblank = final concentration of
particles in tank without mussels
2. Mussel growth
Shell length was measured from the umbo to the ventral margin using digital
calipers (Mitutoyo 500 196-30) with an accuracy of ±0.01mm. Biomass measurements
were made by weighing towel-dried mussels on an analytical balance (Southern
Laboratories) with an accuracy of ±0.001g. Two mussel growth estimates (increase in
shell length and biomass) were determined as the change between final and initial
measurements.
3. Body condition
Three mussels from each subsample period (n=225) were dissected to assess
condition and gonadosomatic indices. We separated the somatic and gonadal tissues,
desiccated each in a drying oven set at 60°C for 48 hours (Quincy Labs), and recorded
their respective dry weights (dw). We calculated the gonadosomatic index (GSI) for each
mussel using the following equation:
GSI= [gonads dw (mg)/total soft tissue dw (mg)] x 100
Additionally, the condition index (CI) was calculated for each mussel using the equation:
CI= [total tissue dw (mg)/shell length (mm)] x 100
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4. Statistical analysis
For each sampling period, we averaged within-tank means for mussel growth,
GSI, CI, and algal clearance parameters. Normality and homogeneity of variances were
assessed through graphical inspection of the model residuals and respective ShapiroWilk’s and Levene’s tests, which indicated a need for data transformation. Algal
clearance data underwent a Box-Cox transformation (Box and Cox 1964) and mussel
growth and body condition data were log-transformed. The assumption of sphericity was
determined for each parameter using the Mauchly test and adjusted using the
Greenhouse-Geisser correction. In order to determine the effects of fluoxetine treatments
on measured response variables we ran repeated-measures ANOVAs with fluoxetine
treatment and sample date as factors with tanks included as an error term to account for
the non-independence between samples. Main effects were considered significant at
α=0.05. Mixed-effects models were generated using the lme4 package in R (Bates et al.
2015). Fluoxetine treatment and sample date were treated as fixed factors while the tanks
were treated as a random factor. Using the multcomp package in R, I generated post-hoc
multiple pairwise comparisons (with a Bonferroni correction) between treatment groups
and sample dates for each measured parameter (See Appendices B-E for pairwise
comparisons of treatment by sample date). All statistical analyses were performed using
R statistical platform (RStudio Version 3.2.2 (2015)).
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Results
1. Algal Clearance
Mean clearance rates differed among treatment groups (ANOVA: F4, 20 = 34.4, P <
0.001, Figure 2.2), being higher in the controls [mean = 63.0 (SE 3.7) cells mL-1min-1]
than in the treatment groups [36.3 (SE 4.2) cells mL-1min-1; Table 1, Figure 2.2]. Mean
clearance rates also differed between sample dates (F10, 20 = 46.0, P < 0.001; Table 2)
being higher towards the end of the study [76.7 (SE 4.7) cells mL-1min-1] than at 30
days since the start [38.2 (SE 3.1) cells mL-1min-1], suggesting that clearance rates were
variable with time. There was an interaction between treatment and sample date (F40, 20
= 3.0, P < 0.001), indicating that the effect of treatment was mediated by sample date.
In general, clearance rates were inversely proportional to fluoxetine concentrations,
where mussels treated with 30 and 300 ng/L cleared algae at a slower rate than the
lower treatment groups (0.3 and 3 ng/L) and controls (see Table 2.1 for full list of
summary statistics).
Table 2.1. Summary statistics from algal clearance trials: mean, minimum, and
maximum values ± SE. Clearance rates were calculated as cleared algal cells mL-1min-1.
Treatment
Control
0.3 ng/L
3 ng/L
30 ng/L
300 ng/L

Mean
63.0 ± 3.7
45.2 ± 3.7
41.8 ± 4.2
31.9 ± 4.2
26.3 ± 4.6

Min
38.8 ± 1.8
19.8 ± 2.6
18.7 ± 3.8
18.6 ± 3.4
13.2 ± 1.2
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Max
119.2 ± 4.3
93.3 ± 2.7
75.1 ± 4.9
57.9 ± 8.3
47.0 ± 7.8

2. Mussel growth
Growth in shell length varied by treatment level (ANOVA: F4, 20 = 22.6, P < 0.001,
Table 2, Figure 2.3 A), with faster growth in controls [0.22 (SE 0.04) mm] than in
treatment [0.12 (SE 0.02) mm; Figure 2.3 A] groups. While there was also an effect of
the sample date (F2, 20 = 18.7, P < 0.001) there was no interaction between treatment
and sample date (F8, 20 = 0.7, P = 0.3) indicating that treatment effects are not
dependent on sample date. Overall growth in shell length followed a similar pattern
over time: lower treatment groups (0.3 and 3 ng/L) grew at a similar rate to controls and
were much greater than the 30 and 300 ng/L treatment groups. Post-hoc Tukey tests
indicated that controls were significantly different from 3.0 ng/L (P = 0.04) but not 0.3
ng/L (P = 0.08) treatment groups, while 30 and 300 ng/L were not different from each
other (P = 0.81).
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Figure 2.2. Clearance rates of mussels; samples collected during 11 feedings over study
duration. Clearance rates were defined as the amount of cells removed per mL per min
per individual mussel. Note mussels were removed over the study: 21 mussels (day 047), 15 mussels (day 47-67, and 9 mussels (67-107). Error bars reflect the standard error
(SE) of the mean.
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Growth in biomass also differed among treatment groups (ANOVA: F4, 20 = 5.2, P
= 0.005; Table 2), with greater increases in biomass in controls [166.41 (SE 33.32) mg]
than treatment [108.81 (SE 14.06) mg; Figure 2.3 B] groups. However, post-hoc Tukey
test revealed there was no significant difference between controls and 0.3 ng/L treatment
groups (P = 0.17). There was an effect of sample date (F2, 20 = 24.5, P < 0.001) and an
interaction between sample date and treatment (F8, 20 = 2.4, P = 0.04), indicating the
effect of fluoxetine on mussel biomass is dependent on exposure period, specifically with
stronger effects after sample date 47 where the group means diverge. There was no
difference in biomass change among mussels treated with 3 ng/L fluoxetine and those
treated with 30 ng/L (P = 0.29) or 300 ng/L (P = 0.35).
3. Body condition
The gonadosomatic index (GSI) of mussels in control groups was much higher
[28.3 (SE 3.6) GSI] than those treated with any concentration of fluoxetine [8.8 (SE 2.0)
GSI; ANOVA: F4, 20 = 24.9, P<0.001, Figure 2.4 A]. There was only a marginal effect of
sample date on mussel GSI (F2, 20 = 3.5, P= 0.05) and no 2nd order interactions (F8, 20 =
1.2, P= 0.37). There were no differences in mean GSI among fluoxetine treatment
groups. The condition index (CI) was also higher in controls than in treatment groups
(ANOVA: F4, 20 = 5.6, P=0.001, Figure 2.4 B) and there was no difference among
fluoxetine treatment groups.
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Figure 2.3. Mussel growth as the increase in A) shell length (mm), and B) biomass (mg)
across treatment groups over study period. Error bars reflect the standard error (SE) of
the mean.
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Figure 2.4. A) Gonadosomatic and B) condition indices for mussels on day 47, 67, and
107 of the study. Error bars reflect the standard error (SE) of the mean.
20

Table 2.2. Results from Repeated measures ANOVAs, including all factors and 2nd order
interactions. Clearance rate data underwent a Box-Cox transformation; other response
variables were log-transformed. Treatment refers to fluoxetine concentration; sample date
refers to subsample group; P-values <0.05 are shown in bold.
Dependent Variable
Clearance rate

Growth (length)

Growth (mass)

Gondosomatic index (GSI)

Condition index (CI)

Factor

SS

MS

df

Treatment

72.43

18.11

4

34.35

<0.001

Sample date

81.85

8.19

10

45.95

<0.001

Treatment*Sample date

21.20

0.53

40

2.96

<0.001

Error among groups

10.54

0.53

20

Error within groups

35.63

0.18

200

Treatment

18.84

4.71

4

22.64

<0.001

Sample date

4.98

2.49

2

18.70

<0.001

Treatment*Sample date

0.70

0.09

8

0.65

0.73

Error among groups

4.16

0.21

20

Error within groups

5.33

0.13

40

Treatment

3.06

0.76

4

5.19

0.005

Sample date

4.61

2.31

2

24.53

<0.001

2.36

0.04

Treatment*Sample date

1.77

0.22

8

Error among groups

2.94

0.14

20

Error within groups

3.76

0.09

40

Treatment

F

p

21.22

5.31

4

24.93

Sample date

1.49

0.74

2

3.51

<0.001
0.05

Treatment*Sample date

2.09

0.26

8

1.23

0.37

Error among groups

3.45

0.17

20

Error within groups

9.32

0.23

40

Treatment

4.97

1.24

4

5.6

Sample date

1.35

0.51

2

1.0

0.001
0.05

0.7

0.51

Treatment*Sample date

4.12

0.14

8

Error among groups

3.56

0.18

20

Error within groups

6.23

0.16

40

21

Discussion
Our study demonstrates that prolonged exposure to nominal concentrations of
fluoxetine impairs mussel physiology and function. We sampled mussels regularly over
the exposure study to better understand how they respond to fluoxetine over time. Whole
body metrics of fitness like growth in biomass and shell length were only affected over
longer time periods. However, for parameters like the GSI and CI, fluoxetine exposure
concentrations affected organisms by 47 days, without increasing differentiation over
time. Our study builds on previous studies documenting fluoxetine’s effects on aquatic
organisms by identifying organism-level and chronic exposure effects over several
months (e.g., >100 days). By simulating chronic fluoxetine exposure in the laboratory,
we offer a snapshot of how this single contaminant may impair mussels along rocky
intertidal shorelines in the wild.
Mussels like M. californianus regularly clear the water column of algae, suspended
particles, and pollutants, improving water quality and providing a critical ecosystem
function along coastal zones. At locations where fluoxetine impairs mussel filter feeding,
this important ecosystem function may be reduced. Hazleton et al. (2014) conducted a
67-day study with adult freshwater mussels, Lampsilis fasciola, exposed to four
fluoxetine concentrations (0, 0.5, 2.5, and 22.3 µg/L), and assessed impacts on
metabolism, movement, and filtering behavior. They found that mussels dosed with 2.5
or 22.3 µg/L fluoxetine had increased activity levels when compared with controls,
suggesting contaminated animals may be more susceptible to predators and reduced
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energy storage, at least at higher fluoxetine concentrations. Increased activity levels (such
as movement) in M. californianus may explain the reduced filtering function and slower
growth rates. While we did not quantify movement patterns following Hazleton et al.
(2014), we did observe that individual mussels exposed to 30 and 300 ng/L fluoxetine
were more dispersed within the tanks and did not cluster as the controls and 0.3-3 ng/L
treatment groups did. Hazelton and colleagues (2014) did not find clear differences
between algal clearance rates but suggested observing clearance rates over shorter time
periods (< 24 h). Our clearance trials were 3 h and we did see clear differences between
control and treated groups. Further, after day 67 we observed that water clarity was
qualitatively reduced in all 5 of the 300ng/L tanks suggesting that clearance was
impaired.
Because fluoxetine exposure impairs mussel clearance rates, it follows that energy
storage and mussel growth would also be reduced (Bringolf et al. 2010; Hazelton et al.
2014). Munari et al. (2014) exposed the clam Ruditapes phillippinarum to fluoxetine at
six concentrations (0, 1, 5, 25, 125, 625 µg/L) for 7 days and found that haemocyte
proliferation increased significantly in clams exposed to 25, 125, 625 µg/L, while gill
acetylcholinesterase (AChE) activity decreased significantly in clams exposed to 1 or 5
µg/L. Their findings suggest that fluoxetine, at least at higher concentrations, strongly
affects immune parameters and neurotransmission in clams. Franzellitti et al. (2014)
reported similar effects with even lower concentrations of fluoxetine (e.g., 0.03-300
ng/L), where fluoxetine reduced the health status of mussels in numerous cellular
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biomarkers. Specifically, fluoxetine reduced the lysosomal membrane stability in
haemocytes and caused accumulation of neutral lipids in the lysosomes of the digestive
glands. We believe that the low condition index values of mussels treated with fluoxetine
in our study are linked to similar cellular responses, although we quantified only
organism-level metrics. Similarly, we observed reduced growth in shell length and
biomass in mussels exposed to fluoxetine above 3ng/L. After sample date 67, growth
rates decreased for mussels exposed to 30 and 300 ng/L of fluoxetine (see slopes in
Figure 2), suggesting that these concentrations have a stronger effect on growth. However
these patterns would not be apparent from the typical short-term exposure studies of 30
days or less. The findings demonstrate that responses measured over short time periods
may miss the extent to which fluoxetine and other pharmaceutical compounds can affect
marine organisms.
In mussels, serotonin is involved in physiological and behavioral functions such as
gill ciliary activity, oocyte maturation, and the induction of spawning (Stanley et al.
2007; Bringolf et al. 2010; Fong & Ford 2014). Because fluoxetine regulates the reuptake
of serotonin, it is likely the drug increases serotonin levels in mussels (Gibbons &
Castagna 1984). Bringolf et al. (2010) found that fluoxetine accumulates in mussel
tissues and has the potential to disrupt several aspects of reproduction in freshwater
mussels. Despite their strong results, they recommended additional testing to evaluate the
effects of long-term exposure to environmentally relevant concentrations. With our longterm testing, the proportion of reproductive tissue to total tissue (GSI) was markedly
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affected by fluoxetine after 47 days of exposure, a long time period among chronic
exposure studies assessing reproduction. We hypothesize that fluoxetine is concentrated
in mussel tissues over time resulting in a reduction of reproductive potential. A similar
statement can be made about the CI, an assessment of the mussel’s overall health status.
Overall, the energy invested into the gonad and somatic tissues was lower in mussels
treated with fluoxetine than in controls.
Fluoxetine is one of the most widely used antidepressants in the world (Metcalfe et al.
2010). A robust amount of research has documented its occurrence in freshwater (Kwon
and Armburst 2006; Ramirez et al. 2009; Bringolf et al. 2010; Corcoran et al. 2010) and
marine (Kreke and Dietrich 2008; Vasskog et al. 2008) environments. Our study
conditions mimic fluoxetine entering the environment in pulses, such as flushing from
rain events, and organism exposure over time. The findings by Franzellitti et al. (2014) of
the numerous adverse outcomes and fluoxetine bioconcentration at 30 and 300 ng/L
exposure concentrations corroborate our results. Further, with growing human
populations in coastal zones, increasing use of antidepressants like fluoxetine is expected,
suggesting higher future concentrations in the marine environment.
The results of this study serve as a foundation to understand how pharmaceuticals and
other emerging contaminants are affecting marine species and community interactions.
While we found fluoxetine to be a considerable stressor to marine mussels, it is only one
of many stressors on marine organisms (Ankley et al. 2007; Boxall et al. 2009).
Nearshore flora and fauna are exposed to a cocktail of contaminants, many of which (e.g.,
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sertraline (Effexor®; Bossus et al. 2013), carbamazepine (Tegretol®; Martin-Diaz et al.
2009)) have negative effects on freshwater and marine organisms (e.g., Metcalfe et al.
2010; Meredith-Williams 2012). Some studies have assessed pharmaceutical effects on
animal behavior and their potential to alter species interactions (Gaworecki and Klaine
2008; Bossus 2013; Hazelton et al. 2013). Yet, long-term studies examining effects of
multiple compounds are warranted to understand interactive and cumulative organismal
and potential ecosystem level effects (Brausch et al. 2012). To our knowledge no studies
have assessed community or ecosystem responses to pharmaceuticals or other emerging
contaminants, an important step in understanding how these compounds may influence
important inter- and intra-specific interactions. Finally, ecological studies are needed to
assess how these compounds affect ecosystems in a changing world, considering
interactive effects with ocean acidification and other impacts from climate change.
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Chapter 3: Exposure to nominal concentrations of the pharmaceutical fluoxetine increases
predation risk in the mud crab, Hemigrapsus oregonensis

1. Introduction

Predator-prey behavior dynamics are often regulated by a combination of abiotic
and biotic factors (Holt and Lawton 1994; Abrams 2000; Grabowski 2004). Physical
factors such as temperature, salinity, and photoperiod often limit where organisms can
survive (e.g., fundamental niche), while species interactions such as competition,
predation, or facilitation further restrict the spatial and temporal extent of an organism
(e.g., realized niche; Hutchinson 1957; Lima & Dill 1990; De Roos et al. 2003; Chase et
al. 2009). Animal behaviors are rooted within this realized niche wherein individuals
modify their behaviors to balance risks (e.g., predation) with rewards (e.g., access to
resources; De Roos et al. 2003, Brown and Kolter 2004). Often these risk-taking
behaviors are plastic and change depending on the spatial (Morgan et al. 2006) or
temporal (Miller & Morgan 2015) conditions (Snell-Rood 2013). Ecologists are eager to
understand animal behaviors to more accurately predict population-, community-, or
landscape-level processes (Abrams 2000; Shochat et al. 2006; Sih et al. 2012; Balke et al.
2014).
Yet, there is a growing list of human-driven impacts that alter animal behavior,
setting additional boundaries on an animal’s realized niche (Barros 2001; Frid & Dill
2002; Fahrig 2007; Dodd et al. 2015). Fisheries have historically removed large
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predators, modifying community behaviors through release from predation pressure
(Myers & Worm 2003; Catano et al. 2015). Anthropogenic noise pollution in the ocean
has been shown to alter the behaviors of numerous marine mammals (Nowacek et al.
2007). Ocean acidification alters development of larval fishes, disrupting their ability to
detect predator cues and leading to increased mortality (Munday et al. 2010). Exposure to
heavy metals, pesticides, petroleum and other legacy contaminants affect animal
behaviors by altering habitat preference, shifting migration patterns, or increasing
negative species interactions (Fleeger et al. 2003; Khoury et al. 2009; Eades & Waring
2010; Fukunaga et al. 2010). Such alterations to normal behaviors have been linked to
reduced fitness, and changes to population structure and ecosystem function (Frid & Dill
2002; Fahrig 2007; Ings et al. 2009).
Much less studied are the effects of pharmaceuticals and other emerging
contaminants on animal behavior, despite frequent detections of these compounds in the
marine environment (Boxall et al. 2012; Brausch et al. 2012; Gaw et al. 2014).
Pharmaceutical compounds and their derivatives regularly enter estuaries and nearshore
coastal ecosystems via transport of contaminated surface and groundwater runoff,
suspended river sediments, and untreated sewage effluent (Metcalfe et al. 2010; Bringolf
et al. 2010; Khairy et al. 2014). As medical drugs, these compounds are designed to illicit
biological responses and could have considerable effects on organism health, despite
detections at low concentrations (Seiler 2002; Ankley et al. 2007). Prolonged studies on
marine organisms at environmentally relevant concentrations are lacking (Berninger &
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Brooks 2010; Gaw et al. 2014). Most pharmaceutical exposure studies are rooted in
ecotoxicological methodology focused on adverse outcomes at the cellular or subcellularlevel (Boxall et al. 2012). Exposure studies that assess the effects of pharmaceuticals on
whole-organism effects, and multi-organism or community-level interactions are needed
to improve ecological inferences and predictions (Fleeger et al. 2003; Brooks et al. 2009;
Corcoran et al. 2010; Gaw et al. 2015).
Mesocosm and tank experiments are often used to assess animal behavior
responses to stressors, particularly when the stressor cannot be controlled in the field.
These include studies where different combinations of stressors such as chemical cues,
temperature, or pH are manipulated in order to measure the behavioral response (Munday
et al. 2009; Dodd et al. 2015). Pharmaceutical contaminants as stressors require a similar
approach to determine if detected or projected concentrations affect organism behaviors
(Hellou 2011; Mesquita et al. 2011; Lazzara et al. 2012; Maranho et al. 2015). Relatively
few studies have assessed how pharmaceuticals affect interspecific behaviors such as
predator-prey interactions (Brodin et al. 2014; Gaw et al. 2014). Yet several studies have
demonstrated alterations in behavior that could lead to increased predation and mortality
(Corcoran 2010; Schultz et al. 2011; Hazelton et al. 2013; Brodin et al. 2014).
Selective serotonin reuptake inhibitor (SSRI) anti-depressants such as fluoxetine
hydrochloride (Prozac®) are among the more prevalent categories of pharmaceuticals
detected in the marine environment (Kreke and Dietrich 2008; Vasskog et al. 2008;
Brodin et al. 2014; Gaw et al. 2014). SSRIs have been developed to delay the reuptake of
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serotonin, moderating neurotransmission in the human brain. In crustaceans, serotonin is
well known to affect behaviors through stimulating the release of hyperglycaemic,
neurodepressing, moult-inhibiting, and gonad-stimulating hormones (Fong and Ford
2014). McPhee and Wilkens (1989) found that Carcinus maenas injected with serotonin
displayed increased activity levels during the day, whereas normally they are
photonegative with increased activity at night. In the same crab species, fluoxetine
significantly altered locomotor behaviors at 120 μg/L (Mesquita et al. 2011). Several
other studies have demonstrated that fluoxetine leads to adverse physiological and
behavioral outcomes in aquatic organisms that could alter their functional roles within the
community (Perreault et al. 2003; Lynn et al. 2007; Stanley et al. 2007; Mennigen et al.
2010; Schultz et al. 2011; Dzieweczynski & Herbert 2012; Kohlert et al. 2012; Bossus et
al. 2013; Barry 2013; Munari et al. 2014; Chen et al. 2015).
Using a controlled laboratory set up, we designed a study to assess the behavior of
the mud crab, Hemigrapsus oregonensis, following exposure to the pharmaceutical
contaminant, fluoxetine. Fluoxetine has been frequently detected in coastal areas at low
concentrations (0.03ng/L -300 ng/L) and is considered toxic to fish and marine
invertebrates (Brooks et al. 2003). In our study, aquarium habitats were designed to
emulate estuarine conditions to assess alterations of H. oregonensis behaviors under the
influence of fluoxetine at controlled concentrations (3 and 30ng/L). We conducted
diurnal and nocturnal behavior trials to assess whether fluoxetine altered the risk-taking
behaviors of H. oregonensis in response to a predator, the red rock crab Cancer
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productus. Our study is one of the few studies to assess how pharmaceutical
contaminants may affect risk-taking behavior in marine animals.

2. Material and methods
2.1. Study Animals
The Oregon mud crab, Hemigrapsus oregonensis (Dana, 1851; Figure. 1A), is a
small intertidal shore crab belonging to the family Grapsidae, and is one of the most
common species inhabiting estuarine shorelines between Resurrection Bay, Alaska and
Bahia de Todos Santos, Baja California. They forage mostly at night, with a diet
consisting primarily of diatoms and green algae, but they will eat carrion and other meat,
if available (Lindberg 1980). H. oregonensis spend most of their time on, beneath, or near
rocks in gravel and fine sediment substrate. To escape predators, H. oregonensis often
quickly burrow in mud or hide beneath rocks; they also rely on camouflage while
remaining motionless (Lindberg 1980). Because H. oregonensis inhabit the soft
sediments of estuaries, they are likely exposed to contaminants, including fluoxetine; in
estuaries, fluoxetine concentrations have been detected as high as 30ng/L (Franzellitti et
al. 2014). For this reason, I chose these crabs as a model organism for fluoxetine
exposure during behavioral trials.
Red rock crabs, Cancer productus (Randall, 1839; Figure 3.1 C), are one of
several Cancer species that inhabit the Pacific Coast of North America, occupying a
similar range as H. oregonensis. They range from sub- to intertidal habitats, but will
regularly occur in estuarine habitats during high tide (McGraw 2005). They regularly
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prey on barnacles, amphipods, intertidal invertebrates, and smaller crabs, including
Hemigrapsus spp. I chose C. productus as my model predator because of its overlapping
range at high tide, whereby the predator may enter an estuary contaminated with
fluoxetine and encounter prey species such as H. oregonensis.

2.2. Experimental holding conditions
H. oregonensis and C. productus crabs were collected from a single location
along an estuarine shoreline in Netarts Bay, Oregon (45°24’51.21”N, 123°56’4.38”W) on
June 15, 2015. C. productus were caught using crab traps deployed at high tide while H.
oregonensis were hand captured along the edge of the shoreline. Both species were
transported in chilled seawater to the laboratory at Portland State University. Upon
arrival, H. oregonensis (n= 90) were sorted, measured, and randomly distributed into 30
housing tanks (~64 L, 3 crabs in each). C. productus (n= 15) were sorted into three
designated housing tanks (~120 L, 5 in each) to prevent cross contamination following
exposure to fluoxetine during behavioral trials. Each housing tank had an independent
water chilling and filtration system (Aquatic Enterprises). Seawater was prepared using
Instant Ocean® and deionized water; salinity and temperature were maintained at 35 PSU
and 16.0 °C to replicate conditions at the collection site. To reduce buildup of animal
waste products, 20% of the seawater was replaced with fresh seawater every 20 days. I
monitored water chemistry (i.e., ammonia, pH, nitrate, and nitrite) every two weeks to
ensure levels were appropriate for crabs. Water criterion was adequate each time. Light
cycle conditions were maintained at 10 h of dark and 14 h of daylight. Animals were
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allowed to acclimate to aquarium habitats (Figure 3.1 A and B) and laboratory conditions
for 2 weeks before the exposure study began. During the acclimation period, crab health
and condition were monitored. A total of 8 H. oregonensis died during acclimation and
were immediately replaced with one of the extra crabs of the same gender and size class
from the original collection. During the exposure study (60 days), 31 crabs perished
either through predation by C. productus during trials (n=18) or through conflicts
between conspecifics (n=13), in which case each was immediately replaced by an
individual of the same size class and gender.
Every two days, H. oregonensis were fed a diet of either squid or shrimp pieces.
In addition, H. oregonensis regularly grazed algae from rocks and sediment and filter fed
by rapidly beating their third maxillipeds near their mouth. C. productus were fed squid
every 2 days. At the end of the study I sacrificed all H. oregonensis, and quantified the
number of appendages lost as a proxy for aggression among conspecifics.
2.3. Experimental design
The experiment followed a repeated measures design in which the tank was the
subject measured at each time point (day vs. night periods, with vs. without predators,
and multiple times for each period and trial type) and was nested within the betweenmeasures factor, fluoxetine treatment. The fluoxetine treatments consisted of 3
concentrations: 0, 3, and 30 ng/L which are the range detected in estuarine and harbor
waters (Kreke and Dietrich 2008; Vasskog et al. 2008). Each treatment group was
comprised of 10 replicates. Each fluoxetine treatment concentration (3.0 and 30.0 ng/L)
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was reached using separate dosing solutions prepared through serial dilution of the
original stock solution of 1.0 mg/mL fluoxetine hydrochloride (Sigma-Aldrich) dissolved
in nanopure water. Every 10 days, tanks were dosed by spilling 193µL of the appropriate
fluoxetine dosing solution into each tank. Controls without fluoxetine received 193µL of
nanopure water on dosing days.
Three H. oregonensis were assigned to each tank, with 1 dominant male, 1
subordinate female, and 1 subordinate male. While we recorded the behavior of each
animal, our experimental units were the individual tanks (n=30) with 10 replicate tanks
nested within each treatment group. Weekly behavioral trials were our observational
units, where all animals in each tank were observed for one-hour periods at day and night
times, both with and without predators present (4 trial types over 9 weeks, n=36). Nopredator trials were used as a reference for assessing behaviors without any perceived
threats.
2.4. Behavioral Trials
Housing tanks were designed to simulate the estuarine conditions from which H.
oregonensis were collected. Each tank was filled with sand (500g) and small pebbles
(500) for burrowing substrate and one large rock (600-750g) to hide under (Fig. 1c).
Tanks were assembled on 3 racks (10 tanks per rack) with sides between tanks blacked
out with plastic lining to maintain behavioral isolation. Each tank contained 3 H.
oregonensis: 1 large dominant male (mean carapace width (CW) ± SE = 25.54 ± 0.42
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mm; mean biomass ± SE = 9.3 ± 1.4 g), 1 small female (CW = 19.25 ± 0.74 mm; 3.6 ±
1.5 g), and 1 small male (21.29 ± 0.65; 4.97 ± 0.97 g). Mean size of crabs did not differ
among treatments or tanks (one-way ANOVA, P > 0.4 in both cases). This density of
crabs (3.0 / 30 cm2) is within the natural range of H. oregonensis densities at the
collection site (densities as high as 20 crabs/50 cm2 were observed). We kept crab
densities low to allow enough space for escape from the much larger C. productus (range:
100 to 150 mm CW) during predator addition trials.
Hour-long trials were recorded using ethograms with common crab behaviors
outlined for each animal. These behaviors were organized by category: Still, active,
foraging, aggression, non-aggression, avoidance, and predator avoidance behaviors. Still
behaviors included: buried, unmoving, moving mandibles only. Active behaviors
included: walking, digging, swimming and moving in place. Foraging behaviors were
those where crabs were probing, handling, or eating food. Aggression, non-aggression,
and avoidance behaviors were defined as interactions between conspecifics such as
fighting, charging, mating, or avoiding one another. Predator avoidance behaviors were
interspecific, where H. oregonensis displayed escape or non-escape behaviors in the
presence of C. productus. We also noted the number of H. oregonensis captured or killed
by C. productus.
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Figure 3.1. Pictures of A) an Hemigrapsus oregonensis in the aquarium habitat, B)
example of the tank set up with sides blacked out, C) addition of Cancer productus
during predator trials, and D) an observer recording crab behavior during a night trial.

Following procedures outlined by Altmann (1974) observers recorded the
behavioral acts of all individuals in each tank via instantaneous scan sampling at 5 min
intervals for 1 hour. Scans lasted 30 seconds, allowing the observer to record acts of
individuals in 10 tanks before returning to the first tank for the next interval. A total of 12
acts were recorded for each animal during the hour period. Day trials were conducted
from 10:00-11:00 am and night trials were conducted from 7:00-8:00pm. During night
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trials, we used red LED lights to record observations while avoiding the effects of visible
light wavelengths on nocturnal behaviors (Figure 3.1.D). No-predator trials for both day
and night trials preceded predator trials by 24 hours with 80 hours in between each
week’s two predator trials to allow crabs to recuperate. All trials were conducted from
June 29 to August 27, 2015.

2.5. Statistical Analysis
Ethograms from the trials were analyzed for crab behavior and predation risk. I
assessed the effect of fluoxetine treatment on H. oregonensis diurnal and nocturnal
behaviors by examining the differences in the proportions of active, foraging, agonistic,
and predator avoidance behaviors in trials with and without predators. To determine these
proportions, I a priori divided active behaviors (i.e., walking, digging, and interactions
between conspecifics) and non-active behaviors (i.e., remaining still, buried, or just
moving mandibles); foraging and non-foraging behaviors; as well as agonistic and nonagonistic behaviors. Predator avoidance behaviors were also a priori determined as
remaining buried, still, or retreat under rock/elsewhere in tank and non-avoidance
behaviors as remaining active, foraging, or interacting without response to the predator.
Within each trial type (no predator/predator) and time of day (day/night) I tested
whether the effect of fluoxetine treatment on behavioral proportions varied across crab
sex and gender. Specifically, I tested the probability of successfully exhibiting behavioral
acts using mixed-effect generalized linear models (GLMM) fitted with a binomial error
distribution using the glmer function in the lme4 package (Bates et al., 2015) in R Studio
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(R Core Team, 2015). Behavioral proportional data was over-dispersed, indicating a
need to fit the logistic regression with a random intercept (the 30 individual housing
tanks). The random effect of the tanks accounts for variance structure between
observations made on the same animals overtime. A separate GLMM was fitted to each
behavior in question (i.e. active, foraging, agonistic, and predator avoidance) to
determine if the effect of fluoxetine treatment varied among crab gender and status. In all
GLMMs the proportional data underwent logit transformation to ensure normality and
homoscedasticity of the residuals.
For behavioral GLMMs, I added components to the null model (i.e., random
intercept) stepwise to determine if they improved the model fit based on Akaike
information criterion (AIC). Components that significantly benefitted the full model fit
included: fluoxetine treatment groups and crab gender and status. In all models, the
length of fluoxetine exposure (in weeks) was not significant (likelihood ratio test, LRT, P
> 0.3 in both cases) so exposure time was not included. Post hoc multiple comparisons
of the models were generated using the multcomp package in R (Hothorn et al. 2008).

3. Results
Active behaviors
The effect of fluoxetine on H. oregonensis active behaviors varied across trial
types and time of day (glmer, likelihood ratio test (LRT), χ2 (2) = 292.31, P < 0.0001,
Figure 3.2). A crab exposed to 30 ng/L of fluoxetine had the highest probability of
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exhibiting active behaviors when predators were absent at night (predicted probability of
active behavior =0.79) and during the day (0.68). When predators were present the
probabilities declined for both time periods (0.62, 0.60, respectfully).
During the day when predators were not present, fluoxetine affected H.
oregonensis (χ2 (2) = 23.78, P < 0.001, Figure 3.2), increasing the proportion of active
behaviors when exposed to 30 ng/L of fluoxetine (estimate ± SE; 1.23 ± 0.27, P <0.001).
The effect of 3ng/L and control groups on active behaviors were negative (-1.37 ± 0.19
and -0.29 ± 0.27, respectively), indicating that crabs in these treatments spent a greater
proportion of their time being still relative to the 30ng/L group.). Crab gender and status
did not significantly explain the variation of active behaviors alone (χ2 (2) = 4.73, P
=0.09), however the interaction between fluoxetine treatment and crab gender and status
significantly improved the model fit (χ2 (6) = 72.95, P <0.001). Dominant males were
more active than females and subordinate males (estimate 0.44 ± 0.11 vs. -0.09 ± 0.11
and -1.50 ± 0.20, P <0.001 in both cases). However subordinate males were more active
when exposed to 30 ng/L of fluoxetine compared with controls (P=0.02).
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Figure. 3.2. Proportions of H.oregonensis day and night behaviors by gender, status, and
fluoxetine treatment when no predators are present. Circles indicate proportions (yellow
= active, red = agonistic, blue = foraging); genders (M/F); status (Dom=dominant,
Sub=subordinate).
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Foraging behaviors
Fluoxetine exposure affected foraging behaviors as well (χ2 (2) = 13.77, P
=0.001), although this effect was mediated by the gender and status of the crab (χ2 (6) =
82.68, P <0.001). Dominant males and subordinate females in 30ng/L spent a greater
proportion of time foraging during the day than their counterparts in control groups
(P<0.01, in both cases), however subordinate males did not differ significantly (P=0.22).
Fluoxetine had a strong effect on nocturnal foraging behaviors (χ2 (2) = 8.21, P = 0.02).
Both dominant and subordinate males exposed to 30 ng/L of fluoxetine significantly
increased their foraging behaviors at night (P<0.001, P=0.001, respectively), however in
females there was no treatment effect (P>0.5, in all cases).
Agonistic behaviors
Crab aggression varied across treatment combinations and time of day (χ2 (8) =
18.63, P = 0.002). The proportion of aggressive acts among H. oregonensis was low
across all treatments (range: 0.008-0.03), but crabs exposed to 30 ng/L fluoxetine were
predicted to have the highest probability of aggressive behavior (0.03) compared to
0.3ng/L (0.01) and control crabs (0.008). Post-hoc Tukey contrasts indicated significant
differences between controls and 30ng/L treatment groups (P < 0.001 in all cases).
Controls and 0.3ng/L groups only differed when the predator was added (P= 0.007),
where 0.3ng/L crabs exhibited slightly more aggressive behaviors (0.005) than the
controls (0.0002, Figure 3.3). Nocturnal agonistic behaviors were higher than diurnal
agonistic behaviors yet were also affected by fluoxetine (χ2 (2) = 20.27, P <0.001).
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Figure. 3.3. Proportions of H.oregonensis day and night behaviors by gender, status, and
fluoxetine treatment when predators are present. Circles indicate proportions (yellow =
active, red = agonistic, blue = foraging); genders (M/F); status (Dom=dominant,
Sub=subordinate).
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Predator avoidance behaviors
Predator avoidance behavior also varied across treatments and time of day (χ2 (8)
= 220.17, P < 0.0001, Figure 3.3). Control crabs were most likely to avoid predators
during the day (predicted probability of predator avoidance = 0.92) and at night (0.75)
compared to crabs exposed to 3 ng/L (0.61 during the day; 0.57 at night), or 30 ng/L of
fluoxetine (0.37 during the day; 0.40 at night). When predators were added during the
day, crabs generally decreased active, foraging, and agonistic behaviors. However, crabs
treated with 30 ng/L did not show a significant decrease in these behaviors when
compared with 3 ng/L and control groups (χ2 (2) = 43.78, P < 0.001, Figure 3.2).
Fluoxetine exposure had a strong negative effect on predator avoidance behaviors despite
crab gender or status (LRT, d.f. = 7, 9, χ2 = 51.11, P < 0.0001). However the predator
avoidance behaviors of males were more affected by fluoxetine exposure than for females
(See Figure 3.2. for a list of proportions of predator avoidance behaviors by gender and
status). More crabs were captured and predated upon by C. productus in the 30 ng/L
treatment group (n=8) than in the control and 3 ng/L groups (n=5 in each). Neither
predator avoidance nor active behaviors varied over time (lm, F1,21=2.5, P = 0.23;
F1,21=1.5, P=0.23, respectively).
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Table. 3.1. Mean proportions of H. oregonensis predator avoidance behaviors (± SE) by
fluoxetine treatment and time of day. Arranged by crab gender (♂/♀) and status
(dominant = Dom/subordinate = Sub).

Day

Night

Control
Dom ♂

0.91 ± 0.01

0.69 ± 0.04

Sub ♂

0.89 ± 0.02

0.76 ± 0.02

Sub ♀

0.81 ± 0.02

0.61 ± 0.04

3.0 ng/L
Dom ♂

0.57 ± 0.02

0.57 ± 0.04

Sub ♂

0.64 ± 0.03

0.67 ± 0.02

Sub ♀

0.57 ± 0.03

0.45 ± 0.04

30.0 ng/L
Dom ♂

0.41 ± 0.03

0.41 ± 0.03

Sub ♂

0.42 ± 0.02

0.36 ± 0.03

Sub ♀

0.41 ± 0.02

0.37 ± 0.03
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Figure. 3.4. Proportions of H. oregonensis day and night behaviors by gender, status, and
fluoxetine treatment representing the difference between no predator and predator trials
(i.e., the predator effect). Circles indicate proportions (yellow = active, red = agonistic,
blue = foraging); genders (M/F); status (Dom=dominant, Sub=subordinate). Points above
the line indicate scenarios in which a behavior was greater in the presence of a predator.
45

4. Discussion

In the presence of predators, prey will often modify their behaviors to balance the
risk of mortality with the reward of accessing food, mates, or other resources (Weis 2010;
Sih et al. 2012; Snell-Rood 2013; Catano et al. 2015). Prey may reduce their activity
levels, utilize defenses, or seek refuge when they perceive the risk to be high (Lindberg
1980, Lima & Dill 1990; Preisser et al., 2007). We assessed whether the risk-taking
behaviors of H. oregonensis would be altered under the influence of fluoxetine, a
pharmaceutical contaminant commonly detected in estuaries and harbor waters (Kwon
and Armburst 2006; Kreke and Dietrich 2008). Crabs exposed to the highest level of
fluoxetine were more likely to be active and exhibit risk-taking behaviors in the presence
of C. productus, resulting in a greater probability of predator capture and mortality. In
fact, more crabs were captured by C. productus in the higher fluoxetine treatment than in
the 3 ng/L or control treatments. Crabs in control groups exhibited a greater probability
of predator avoidance behaviors because they reduced their activity levels and/or actively
sought refuge when the predator was an immediate threat. Our results suggest that
fluoxetine stimulates crab activity levels and reduces their inhibition to predator threats.
For crabs inhabiting harbors or estuaries contaminated with fluoxetine, the changes to
their normal behaviors may place them at greater risk of injury and mortality, with
potential community-level effects.
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I designed this experiment to simulate estuarine conditions in the laboratory,
whereby H. oregonensis could reside in a similar habitat while exhibiting somewhat
natural behaviors. I controlled between tank variation by maintaining identical abiotic
conditions (e.g., light, temperature, salinity) and habitat substrate (e.g., rocks, gravel, and
sand) across treatments. Therefore I propose that the differences in crab behavior
reported here were attributable to fluoxetine rather than experimental artifacts. The 59
crabs that survived until the end of the trials (60 days) were likely overexposed to crab
predators although we did not see a pattern of learned tolerance of predator presence. We
believe any learned tolerance was minimal because 1) we allowed for sufficient time
between predator trials (i.e., 80 hours); 2) we did not preclude C. productus from
predating on H. oregonensis during the trials; and 3) predator induced mortality did not
decline over time. Further, our observed proportions of crab active and predator
avoidance behaviors did not change significantly over the length of the study, which we
would expect if H. oregonensis learned to not perceive C. productus as a threat. Rather,
the variability in H. oregonensis risk-taking behaviors remained fairly low across
treatments during predator trials (see mean proportions by week in Figure 3.3).
Our predictive models were best fit by the interactions between treatment
combinations and time of day, which suggests that crab behavior was mediated by
photoperiod. Like other crabs, H. oregonensis are photonegative, increasing activity
levels and foraging primarily at night. Assuming crabs in control groups serve as a
reference, exhibiting the most ‘typical’ behaviors, we would expect higher activity
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amongst all crabs during night trials. However, crabs exposed to 30 ng/L-spiked water
exhibited twice as much active behavior at night as control groups, suggesting a strong
effect of fluoxetine. Interestingly, there was little difference between diurnal and
nocturnal activity levels in crabs exposed to 3ng/L of fluoxetine. Perhaps photoperiod
was not as important for regulating activity in this treatment group, since predator
avoidance behaviors were also low. From our observations, crabs in this group appeared
to be the least affected by the addition of the crab predator, as evidenced by the lack of
behavioral alterations between trial type (Figures 3.2. and 3.3).
Serotonin and serotonin analogs have been shown to alter agonistic behaviors
(McPhee & Wilkens 1989; Tierney & Mangiamele 2001) and activity levels (PerezCampos et al. 2012; Fong & Ford 2014) in crustaceans. Fluoxetine in concentrations
equal or greater than 120µg L-1 caused a stimulation of locomotor behavior in the crab
Carcinus maenas (Mesquita et al. 2011). We found similar increases in agonistic
behaviors of crabs exposed to 30ng/L of fluoxetine, but with much lower exposure
concentrations than in Mesquita et al. (2011). In Chasmagnathus crabs, Pedetta et al.
(2008) modulated the individual aggressiveness via manipulation of serotonin and
octopamine levels, where aggressiveness increased and decreased with the addition of the
respective hormone. Perhaps fluoxetine, through modulation of serotonin levels,
stimulates crab activity levels and drives the observed aggressive behaviors. Further, our
results demonstrate that fluoxetine may inhibit predator avoidance behaviors. The drug’s
effect on serotonin levels appears to increase boldness and potentially other risk taking
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behavior as studies on other species have suggested (Tierney & Mangiamele 2001;
Pedetta et al. 2010; Mesquita et al. 2011; Dzieweczynski & Herbert 2012; Fong & Ford
2014).
Fluoxetine is one of the most widely used antidepressants in the world (Metcalfe
et al. 2010). A robust amount of research has documented its occurrence in aquatic
(Kwon and Armburst 2006; Ramirez et al. 2009; Bringolf et al. 2010; Corcoran et al.
2010) and marine (Kreke and Dietrich 2008; Vasskog et al. 2008) environments. With
growing human populations in coastal zones, increasing use of antidepressants like
fluoxetine is expected, suggesting higher future concentrations in the marine
environment. Our results demonstrate how pharmaceuticals and other emerging
contaminants may affect species behaviors and their interactions. Brodin et al. (2014)
summarized several ecologically important behavioral traits for assessing sublethal
effects of pharmaceutical exposure, and potential direct or indirect ecological effects.
These behavioral traits include: activity, aggression, boldness, exploration, and sociality.
Each of these behavioral traits lead to direct ecological effects such as cooperation,
dispersal/migration, feeding rates, mating success, parental care, and predator avoidance.
These direct effects can be linked to differences in community structure, cross-boundary
effects, ecosystem function, feedback loops, population dynamics, and trophic cascades.
Anthropogenic impacts to coastal systems such as ocean acidification, warming surface
water temperatures, and pollution have all been identified as significant environmental
stressors, altering much of the aforementioned ecosystem processes (Munday et al. 2009;
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Fukunaga et al. 2010; Dodd et al. 2015). Since pharmaceuticals have been shown to
affect many of the same processes through similar mechanisms, they warrant
consideration as an important environmental stressor in need of further research.
Estuarine and coastal organisms are exposed to whole suites of contaminants,
many of which (e.g., sertraline (Effexor®; Bossus et al. 2013), carbamazepine
(Tegretol®; Martin-Diaz et al. 2009)) have negative effects on aquatic and marine
organisms (e.g., Metcalfe et al. 2010; Meredith-Williams 2012; Gaw et al. 2014; Fong &
Ford 2014). Our study and others have assessed the effects of single pharmaceuticals on
animal behavior and their potential to alter species interactions (Gaworecki and Klaine
2008; Bossus 2013; Hazelton et al. 2013). Yet, additional studies examining the effects of
multiple compounds are warranted to understand interactive and cumulative effects on
organisms and ecosystems (Brausch et al. 2012; Brodin et al. 2014). Further, studies that
assess how pharmaceuticals interact with lower pH (i.e., ocean acidification conditions)
would add to the growing field of multiple stressor research. To our knowledge no
studies have assessed community or ecosystem responses to pharmaceuticals or other
emerging contaminants, an important step in understanding how these compounds may
influence important inter- and intra-specific interactions. Finally, it would be
advantageous for both ecology and ecotoxociology to merge components of
pharmaceutical contaminants research, as both disciplines use similar species and
examine similar endpoints while addressing separate questions. If we are to truly
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understand how pharmaceuticals may act as stressors to marine ecosystems, we need to
learn from the collective work in this emerging field.
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Chapter 4: Conclusions

This case study of fluoxetine builds on previous studies documenting fluoxetine’s
effects on aquatic organisms by identifying the chronic exposure effects (47-107 days) on
organism health, behavior, and functioning. The results from the two different
experiments indicate that fluoxetine is a considerable environmental stressor, even at the
low concentrations detected in the marine environment. Specifically, nominal
concentrations of fluoxetine significantly affect both mussel and crab physiology and
behavior, which may negatively affect individual fitness and species interactions. While
both studies involve only one or two species, the implications of the results suggest that
fluoxetine exposure could affect community- or ecosystem-level processes. By
simulating chronic fluoxetine exposure in the laboratory we offer a snapshot of how this
single contaminant may serve as an environmental stressor to invertebrates along rocky
intertidal and estuarine shorelines in the wild.
Fluoxetine is one of the most widely prescribed antidepressants in the world and a
significant amount of research has documented its occurrence and negative effects on
organisms in aquatic and marine environments. With growing human populations in
coastal zones, increasing use of antidepressants, like fluoxetine, is expected, suggesting
higher future concentrations in the marine environment. We have demonstrated that
fluoxetine reduces M. californianus algal clearance rates, growth, and reproductive
potential at very low concentrations. We also found that similar low concentrations
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increased predation susceptibility by stimulating activity levels and risk-taking behaviors
in H. oregonensis. For mussels and crabs inhabiting harbors or estuaries contaminated
with fluoxetine, the changes to their normal behaviors and functioning may yield
community-level consequences.
The results of this study serve as a foundation to understand how pharmaceuticals
may act as emerging environmental stressors, affecting marine species and their
interactions. While we found fluoxetine to be a considerable stressor to marine mussels
and crabs, it is only one of many stressors on marine organisms. Other studies have
assessed how individual pharmaceuticals may affect animal behavior and health, and
their potential to alter species interactions. These collectively fill important data gaps
with respect to emerging contaminant research. However, long-term studies examining
the effects of multiple stressors, such as multiple pharmaceuticals or the combination of
pharmaceuticals with ocean acidification or other pollutants, are warranted to understand
interactive and cumulative organism and potential ecosystem level effects.
Finally, ecology and ecotoxicology, the two primary disciplines that assess impacts
from pharmaceutical as environmental stressors, need to integrate their research. The
advantage of combining the findings from these two research fields is evident, as
pharmaceuticals in the environment often modify important ecosystem processes. This
project attempts to bridge the two fields by providing data from a hybridized
methodology that combined standardized ecotoxicology testing with ecological
questioning.
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Appendix A. Table of mussel metrics organized by mean ± SE and fluoxetine treatment
group. Total biomass was the aggregate wet biomass of mussels per tank (n = number of
mussels).
Fluoxetine
Treatment

Initial Length
(mm)

Initial Mass
(g)

Total Biomass (g)
n =21

Total
Biomass (g)
n = 15

Control

32.67 ± 0.31

4.39 ± 0.14

90.33 ± 1.26

63.11 ± 1.33

34.02 ± 1.30

0.3 ng/L

32.55 ± 0.44

4.18 ± 0.11

86.95 ± 0.71

59.61 ± 1.29

35.36 ± 0.63

3 ng/L

31.78 ± 0.32

4.02 ± 0.14

84.15 ± 1.14

59.95 ± 1.30

35.28 ± 1.64

30 ng/L

31.58 ± 0.36

4.03 ± 0.12

84.12 ± 1.66

56.38 ± 0.51

33.24 ± 0.98

300 ng/L

32.53 ± 0.32

4.33 ± 0.14

90.15 ± 1.06

63.32 ± 1.00

36.46 ± 1.30
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Total
Biomass (g)
n=9

Appendix B. Mussel growth (length) multiple comparison tests by treatment group and
sample date. P-values adjusted by Bonferroni correction.

Growth (length)

Pairwise comparisons

Estimate

Standard Errror

Z - value

P(>|Z|)

Control_67 - 300_67 == 0

1.181

0.252

4.697

<0.01

Control_67 - 30_67 == 0

0.684

0.252

2.720

0.290

Control_67 - 3_67 == 0

0.257

0.252

1.022

1.000

Control_67 - 0.3_67 == 0

0.166

0.252

0.660

1.000

Control_47 - 300_47 == 0

1.303

0.252

5.181

<0.01

Control_47 - 30_47 == 0

1.181

0.252

4.695

<0.01

Control_47 - 3_47 == 0

0.299

0.252

1.190

0.997

Control_47 - 0.3_47 == 0

0.442

0.252

1.757

0.913

Control_107 - 300_107 == 0

1.493

0.252

5.938

<0.01

Control_107 - 30_107 == 0

1.166

0.252

4.635

<0.01

Control_107 - 3_107 == 0

0.289

0.252

1.149

0.998

Control_107 - 0.3_107 == 0

0.234

0.252

0.932

1.000

300_67 - 30_67 == 0

-0.497

0.252

-1.977

0.810

300_67 - 3_67 == 0

-0.924

0.252

-3.674

0.019

300_67 - 0.3_67 == 0

-1.015

0.252

-4.037

<0.01

300_47 - 30_47 == 0

-0.122

0.252

-0.486

1

300_47 - 3_47 == 0

-1.004

0.252

-3.991

<0.01

300_47 - 0.3_47 == 0

-0.861

0.252

-3.424

0.045

300_107 - 30_107 == 0

-0.328

0.252

-1.303

0.994

300_107 - 3_107 == 0

-1.204

0.252

-4.788

<0.01

300_107 - 0.3_107 == 0

-1.259

0.252

-5.006

<0.01

30_67 - 3_67 == 0

-0.427

0.252

-1.698

0.933

30_67 - 0.3_67 == 0

-0.518

0.252

-2.060

0.759

30_47 - 3_47 == 0

-0.881

0.252

-3.504

0.034

30_47 - 0.3_47 == 0

-0.739

0.252

-2.938

0.176

30_107 - 3_107 == 0

-0.877

0.252

-3.486

0.037

30_107 - 0.3_107 == 0

-0.931

0.252

-3.703

0.017

3_67 - 0.3_67 == 0

-0.091

0.252

-0.362

1.000

3_47 - 0.3_47 == 0

0.142

0.252

0.566

1.000

3_107 - 0.3_107 == 0

-0.055

0.252

-0.218

1.000
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Appendix C. Mussel growth (mass) multiple comparison tests by treatment group and
sample date. P-values adjusted by Bonferroni correction.

Growth (mass)

Pairwise comparisons

Estimate

Standard Errror

Z - value

P(>|Z|)

Control_67 - 300_67 == 0

1.432

0.292

4.908

<0.01

Control_67 - 30_67 == 0

1.340

0.292

4.591

<0.01

Control_67 - 3_67 == 0

0.870

0.292

2.983

0.160

Control_67 - 0.3_67 == 0

0.957

0.292

3.279

0.071

Control_47 - 300_47 == 0

1.428

0.292

4.893

<0.01

Control_47 - 30_47 == 0

1.035

0.292

3.547

0.031

Control_47 - 3_47 == 0

1.442

0.292

4.941

<0.01

Control_47 - 0.3_47 == 0

1.299

0.292

4.452

<0.01

Control_107 - 300_107 == 0

1.741

0.292

5.968

<0.01

Control_107 - 30_107 == 0

1.589

0.292

5.444

<0.01

Control_107 - 3_107 == 0

0.891

0.292

3.054

0.133

Control_107 - 0.3_107 == 0

1.202

0.292

4.119

<0.01

300_67 - 30_67 == 0

-0.092

0.292

-0.317

1.000

300_67 - 3_67 == 0

-0.562

0.292

-1.925

0.841

300_67 - 0.3_67 == 0

-0.475

0.292

-1.629

0.953

300_47 - 30_47 == 0

-0.393

0.292

-1.346

0.992

300_47 - 3_47 == 0

0.014

0.292

0.047

1.000

300_47 - 0.3_47 == 0

-0.129

0.292

-0.441

1.000

300_107 - 30_107 == 0

-0.153

0.292

-0.524

1.000

300_107 - 3_107 == 0

-0.850

0.292

-2.914

0.191

300_107 - 0.3_107 == 0

-0.539

0.292

-1.849

0.878

30_67 - 3_67 == 0

-0.469

0.292

-1.609

0.957

30_67 - 0.3_67 == 0

-0.383

0.292

-1.313

0.993

30_47 - 3_47 == 0

0.407

0.292

1.394

0.988

30_47 - 0.3_47 == 0

0.264

0.292

0.905

1.000

30_107 - 3_107 == 0

-0.698

0.292

-2.391

0.522

30_107 - 0.3_107 == 0

-0.387

0.292

-1.325

0.993

3_67 - 0.3_67 == 0

0.086

0.292

0.296

1.000

3_47 - 0.3_47 == 0

-0.143

0.292

-0.489

1.000

3_107 - 0.3_107 == 0

0.311

0.292

1.066

0.999
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Appendix D. Mussel gonadosomatic index (GSI) multiple comparison tests by treatment
group and sample date. P-values adjusted by Bonferroni correction.

Gonadosomatic Index (GSI)

Pairwise comparisons

Estimate

Standard Errror

Z - value

P(>|Z|)

Control_67 - 300_67 == 0

1.432

0.292

4.908

<0.01

Control_67 - 30_67 == 0

1.340

0.292

4.591

<0.01

Control_67 - 3_67 == 0

0.870

0.292

2.983

0.160

Control_67 - 0.3_67 == 0

0.957

0.292

3.279

0.071

Control_47 - 300_47 == 0

1.428

0.292

4.893

<0.01

Control_47 - 30_47 == 0

1.035

0.292

3.547

0.031

Control_47 - 3_47 == 0

1.442

0.292

4.941

<0.01

Control_47 - 0.3_47 == 0

1.299

0.292

4.452

<0.01

Control_107 - 300_107 == 0

1.741

0.292

5.968

<0.01

Control_107 - 30_107 == 0

1.589

0.292

5.444

<0.01

Control_107 - 3_107 == 0

0.891

0.292

3.054

0.133

Control_107 - 0.3_107 == 0

1.202

0.292

4.119

<0.01

300_67 - 30_67 == 0

-0.092

0.292

-0.317

1.000

300_67 - 3_67 == 0

-0.562

0.292

-1.925

0.841

300_67 - 0.3_67 == 0

-0.475

0.292

-1.629

0.953

300_47 - 30_47 == 0

-0.393

0.292

-1.346

0.992

300_47 - 3_47 == 0

0.014

0.292

0.047

1.000

300_47 - 0.3_47 == 0

-0.129

0.292

-0.441

1.000

300_107 - 30_107 == 0

-0.153

0.292

-0.524

1.000

300_107 - 3_107 == 0

-0.850

0.292

-2.914

0.191

300_107 - 0.3_107 == 0

-0.539

0.292

-1.849

0.878

30_67 - 3_67 == 0

-0.469

0.292

-1.609

0.957

30_67 - 0.3_67 == 0

-0.383

0.292

-1.313

0.993

30_47 - 3_47 == 0

0.407

0.292

1.394

0.988

30_47 - 0.3_47 == 0

0.264

0.292

0.905

1.000

30_107 - 3_107 == 0

-0.698

0.292

-2.391

0.522

30_107 - 0.3_107 == 0

-0.387

0.292

-1.325

0.993

3_67 - 0.3_67 == 0

0.086

0.292

0.296

1.000

3_47 - 0.3_47 == 0

-0.143

0.292

-0.489

1.000

3_107 - 0.3_107 == 0

0.311

0.292

1.066

0.999

68

Appendix E. Mussel condition index (CI) multiple comparison tests by treatment group
and sample date. P-values adjusted by Bonferroni correction.
Pairwise comparisons
Control_67 - 300_67 == 0
Control_67 - 30_67 == 0
Control_67 - 3_67 == 0
Control_67 - 0.3_67 == 0
Control_47 - 300_47 == 0
Control_47 - 30_47 == 0
Control_47 - 3_47 == 0
Control_47 - 0.3_47 == 0
Control_107 - 300_107 == 0
Control_107 - 30_107 == 0
Control_107 - 3_107 == 0

Condition Index

Control_107 - 0.3_107 == 0
300_67 - 30_67 == 0
300_67 - 3_67 == 0
300_67 - 0.3_67 == 0
300_47 - 30_47 == 0
300_47 - 3_47 == 0
300_47 - 0.3_47 == 0
300_107 - 30_107 == 0
300_107 - 3_107 == 0
300_107 - 0.3_107 == 0
30_67 - 3_67 == 0
30_67 - 0.3_67 == 0
30_47 - 3_47 == 0
30_47 - 0.3_47 == 0
30_107 - 3_107 == 0
30_107 - 0.3_107 == 0
3_67 - 0.3_67 == 0
3_47 - 0.3_47 == 0
3_107 - 0.3_107 == 0

Estimate

Standard Errror

Z - value

P(>|Z|)

0.723
0.473
0.544
0.633
0.396
0.497
0.556
0.438
0.782
0.824
0.491
1.118
-0.250
-0.178
-0.090
0.101
0.160
0.042
0.042
-0.291
0.336
0.072
0.161
0.059
-0.060
-0.333
0.294
0.089
-0.118
0.627

0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256
0.256

2.821
1.844
2.125
2.471
1.546
1.941
2.169
1.708
3.054
3.217
1.917
4.364
-0.977
-0.696
-0.349
0.395
0.623
0.162
0.163
-1.137
1.31
0.28
0.627
0.229
-0.232
-1.3
1.147
0.347
-0.461
2.447

0.236
0.880
0.718
0.460
0.969
0.832
0.686
0.931
0.133
0.084
0.844
<0.01
1.000
1.000
1.000
1.000
1.000
1.000
1.000
0.999
0.994
1.000
1.000
1.000
1.000
0.994
0.998
1.000
1.000
0.479
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Appendix F. Plots of residuals from clearance rates model (e.g. mussel experiments).
Model fit a normal distribution after data underwent Box-Cox transformation.
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Appendix G. Plots of residuals from mussel growth (length) model. Model fit a normal
distribution after data was log-transformed.
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Appendix H. Plots of residuals from mussel growth (mass) model. Model fit a normal
distribution after data was log-transformed.
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Appendix I. Plots of residuals from mussel gonadosomatic index model. Model fit a
normal distribution after data was log-transformed.
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Appendix J. Plots of residuals from mussel condition index model. Model fit a normal
distribution after data was log-transformed.

74

Appendix K. Plots of residuals from crab active behaviors model. Model fit a binomial
error distribution.
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Appendix L. Plots of residuals from crab predator avoidance behaviors model. Model fit
a binomial error distribution.
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Appendix M. A record of modification to the initial study proposal
This section provides a detailed record of all modifications made to the study
design and methodology in the initial study proposal. A copy of the proposal is provided
here for reference. Wherever a modification was made to the study design an endnote
was added to provide explanation of the reason for the modification and any other
relevant details.

Project Title: Multiple stressor effects of pharmaceuticals on Oregon’s rocky intertidal
communities: A case study of fluoxetine and carbamazepine

Methods
-Laboratory Experiments1.Animal Collection, Housing and Husbandry
1.1. Collection and Aquaria conditions
I will collect 525, 2-3 cm, Mytilus californianus mussels from the mussel bed at
Boiler Bay, Oregon1. Collected animals will be housed in 60-liter tanks in Portland State
University. Each tank is attached to its own ﬁltration, a biobag ﬁlter will be used to ﬁlter
mussel waste products from the aquaria. Aquarium conditions (e.g., salinity, temperature,
light cycle) will reflect in situ conditions at time of mussel collection. Specifically, water
salinity will be kept between 32 and 35 ppt, using artificial seawater from Instant Ocean
salts. The light cycle will reflect summer daylight hours (14 hours light, 10 hours dark).
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Water temperature will be kept between 12-15 °C (55-60°F) and will be regulated using
non-toxic glycol-based chillers.
Upon arrival at PSU, mussels will be weighed and measured and will then be
divided into three weight classes. From each weight class, 7 mussels will be selected at
random and placed into housing tanks for a total of 21 mussels per tank (21mussels/tank
X 25 treatment tanks with mussels = 525 mussels total). Mussels will be labeled using
different colored acrylic nail polish2. To reduce stress on the animals from handling,
mussels will be placed onto watch glasses for a total of 7 mussels per watch glass.
Mussels will be allowed an acclimation period of 7 days to reattach byssal threads to the
watch glass3. After 7 days, the mass of each watch glass group will then be measured
collectively, and then repeatedly throughout the study, however individual lengths and
widths will be measured separately using a small ruler4.
1.2. Feeding
Mussels will be fed using Shellfish Diet 1800 from Reed Mariculture at amounts
per mussel following Rodriguez del Rey et al. (2011). Each mussel will be fed 0.41 mL
of shellfish diet at each feeding event, every 5 days. 8.61 mL of shellfish diet (0.41mL X
21 mussels/tank)5 will be added to each housing tank using a calibrated syringe. To
measure feeding rates, water samples will be taken 1 minute after adding the shellfish
diet and approximately one hour after, and samples will be collected again. To measure
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differences in chlorophyll a concentration, samples will be analyzed using
spectrophotometry6.

1.3. Water changes
Every 30 days a 75% partial water change will be performed. The biofilter bags
will filter the nitrogenous wastes from mussels, however it is important to replace the
majority of the water each month. This will be done along the same timeline as the 10day dosing for each treatment, including adding 0.01% ethanol (EtOH)7 to the controls
tanks with and without mussels. The 0.01% EtOH will be added to account for the
fluoxetine treatment reagents, which use the ethanol. Tanks will not be allowed to
completely dry because of the risk of damaging bacteria colonies on the biobag filters.
2. Exposure to fluoxetine
2.1. 90-day8 exposure study design
Mussels will be exposed to one of four fluoxetine levels (0.5, 2.0, 5.0, 10.0µg/l)9
following environmentally relevant concentrations determined by Choong et al. (2006).
Two control treatments, with and without mussels, with no fluoxetine (0µg/l) but with
0.01% EtOH will be used to determine if there is an effect of fluoxetine treatment. Using
a block design, there will be 30 tanks with a random assortment of four treatment and two
control types with a total n=5 per treatment (Figure 1). Fluoxetine will be added to
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treatment tanks on day 1, and then added every 10 days to mimic pulse events of
contaminant delivery.

2.1.1 Measurements
a. Growth rates
Each mussel will be identified using rack, tank, watch glass number, and nail
polish color (blue, red, green, purple, yellow, orange, pink) (e.g., 321B = rack 3, tank 2,
watch glass 1, blue). Every 10 days mussels10 will be measured for group wet-weight (per
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watchglass) and individual length and width. Shell thickness of individuals will be
measured by notching their shells at the beginning of the study. Accretion rate11 will be
based on the amount of measured growth over the time interval between measurements
(10 days).

b. Feeding rates
Feeding behavior/rate will be monitored every 10 days12 while the animals are
fed. As outlined above, feeding rates will be measured per tank as a function of the
difference in chlorophyll a concentrations at the time of feeding and 60 minutes after. To
estimate individual feeding rates, the tank measurement will then be divided by the total
number of mussels (n=21).
c. Reproductive function/other physiological responses
Every 30 days13, 6 random individuals from each group will be sacrificed from
each tank to measure gametogenic activity. Here, gametogenic activity is characterized
by measuring the gonadosomatic index (weight of gonad/soft tissue weight; GSI),
following Gagne et al. 2009).
d. Water samples14
To keep a running background of concentrations of fluoxetine for each treatment
tank, water samples will be taken on day one, then every 10 days prior to fluoxetine
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addition, and frozen until analyzed using protocols adapted from Rodriguez del Rey et al.
(2011). Water samples will be collected from the respective tanks in the following order:
control without mussels > control with mussels > 0.5µg/L> 2.5µg/L> 5.0µg/L>10µg/L.
50mL of water from each tank will be extracted using a calibrated syringe and then
filtered through a centrifuge tube with Whatman glass fiber filters into a 50mL centrifuge
tube. These samples will then be frozen until they are ready for preparation and analysis.
Samples will be analyzed using a Fluoxetine enzyme-linked immunosorbent assay
(ELISA) test kit to detect for the presence of fluoxetine.
-Field Experiments-15
1. Study Sites
A 16-week long field experiments will be conducted at the same location as
mussels collected for laboratory experiments, Boiler Bay, OR (44°83’N, 124°06’W).
2. Exposure to Fluoxetine and Carbamazepine
The pharmaceutical drugs carbamazepine and fluoxetine will be used to test H2
and H3, whether there is a cumulative effect of multiple stressors from these
contaminants on mussel growth, byssal thread integrity, and resistance to predation. Six
treatments (fluoxetine (2 levels), carbamazepine (2 levels), fluoxetine + carbamazepine
(lowest and highest level combinations)) and a control (agar) will be administered using
diffusing devices at 4 sites at Yachats (Figure 2). To test for caging effects, cage controls
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(no cages) will be used for each treatment. At these cage control sites, Pisaster will be
removed manually every two weeks.
Because exposure experiments will be used in conjunction with predator
manipulation, predator exclusion cages will be outfitted with contaminant diffusing
systems (CDS). This will consist of wire cages mounted to the rock wall with bolts and a
layer of neoprene to ensure no entry from seastars beneath the wire. The contaminant
diffusion system will be secured to this cage by using a previously assembled PVC
square with 4, one-inch diameter holes drilled into each arm (see Figure 2 for schematic).
Film canisters filled with a set agar gel containing the contaminant (e.g., fluoxetine,
carbamazepine, or both) will be secured into these holes for contaminant diffusion. These
will then be replaced every 4 weeks with a new canister to ensure chronic, near-constant
exposure to mussels within the cages and neighboring mussels. Every 2 weeks, mussel
and seawater samples at 0m (within cage), 0.5m, 1m, 2m, and 5m outside of the CDS
cages will be collected and analyzed using ELISA kits for presence of contaminants.
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a. Mussel Growth
At each exposure level (e.g., distance interval from CDS cage), 10 mussels will be
identified using colored nail polish. Every 2 weeks, total length will be measured.
b. Byssal thread integrity
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The attachment strength of Mytilus californianus will be measured following
methods of Harger (1970). Mussels will be hooked onto a spring dynamometer
(constructed to record maximum force) with a wire loop. A pulling force will be applied
perpendicular to the mussel bed until the hooked mussel is dislodged. This will be done
for 5 mussels at each exposure level every two weeks.
c. Predation intensity experiment
I will measure predation intensity following a design similar to Navaratte and
Menge (1996). In this case the stressors will the individual contaminants or the
combination of the two contaminants and the primary effect will be mussel resistance to
predation. As mentioned earlier CDS cages will be placed within either a control or
treatment plot. In the cages where seastars are removed (P-) cages will have a roof and
four sides. In predator control plots (P+), seastars will have access through cages that
have two open sides, to account for potential caging effects. In control areas without
contamination, CDS cages (two open sides) will be filled with canisters of agar gel.
Every two weeks cages will be monitored and maintained to ensure predator
removal. Small and medium sized seastars, as well as other benthic predators such as
crabs are capable of entering cages. Upon each visit, the number of live and dead mussels
remaining in cages and controls will be counted.
3. Statisical analyses16
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Analysis of variance (ANOVA) will be used to determine if there are differences
between each treatment and the controls. ANOVA assumptions of independence,
normality, and homogeneity of the variances of the residuals will be met by using their
appropriate tests. Tank samples will maintain independence by being isolated from one
another, including water and filtration. Field samples will maintain independence by
having an appropriate amount of space from one another (e.g. >50m). Both field and tank
samples will be tested for normality and equal variance by using the Shapiro-Wilk test
and F-test respectively. All statistical analyses will be performed using R studio version
2.11.1.
1.

M. californianus mussels were collected from a single location on the jetty north of

Rockaway Beach, Oregon (45°39’18.4”N, 123°56’31.2”W)
2.

Mussels were enumerated using super glue and water proof paper labels. Nail polish

flaked off after 2 weeks, during the acclimation period.
3.

Mussels were acclimated for one month, not 7 days.

4.

Mussels were weighed individually on 3 sample dates: 47, 67, 107. On days 47 and 67

mussels were weighed and measured and individuals not sacrificed were placed back in
tanks.
5.

We modified feeding based on feedback from Reed Mariculture: Twice weekly,

mussels were batch fed Shellfish Diet 1800® (Reed Mariculture) diluted tenfold with
seawater. The algae in the Shellfish Diet 1800® is a combination of six marine
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microalgae Isochrysis, Pavlova, Tetraselmis, Chaetocerous calcitrans, Thalassiosira
weissflogii and Thalassiosira pseudonana with cell diameter sizes ranging from 5 to 16
µm. Per mussel volume of algae fed was constant throughout the study.
6.

Clearance rates were determined using the following modified methods: On feeding

days, a 10 mL seawater sample was obtained ~1 minute after the algae mixture was
added to each of the tanks. Mussels were allowed to feed for 3 hours before an additional
10mL sample was extracted. These samples served as initial and final concentrations,
respectively. From each sample, we counted algal cells in three 0.5 mL aliquots using a
Beckman Coulter Counter (model Z1, 100 µm aperture) and determined the mean initial
and final concentrations within each tank. We collected a total of 11 samples over the
course of the 107 day study.
Filtering rates were estimated from the rate of change in suspended particle
concentrations. Following Coughlan (1969), we based filtering rates on four assumptions:
a) the reduction in the concentration of particles is due to filtration by the animal, and to
settling, b) mussel pumping rate is constant, c) particle retention is 100% efficient and d)
there is homogenous suspension of particles. A set of identical tanks without mussels
(n=4) served as blanks for feeding trials. Clearance rates for each mussel were calculated
using the following formula (Coughlin 1969):
CR= (M/n) [ln (C0/Ct)/t] – [ln (C0blank/Ctblank)/t]
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where CR = clearance rate (cells-1mL-1min-1); M = volume of seawater in each tank (mL);
n = number of mussels in tank; t = feeding time (min); C0 = initial concentration of
particles in tank; Ct = final concentration of particles in tank. C0blank = initial
concentration of particles in tank without mussels; Ctblank = final concentration of
particles in tank without mussels
7.

Because fluoxetine is water soluble, we did not use 0.1% EtOH to increase the

solubility of the solid. Fluoxetine hydrochloride was dissolved only in nanopure water.
8.

Study period was 107 days for mussel experiment

9.

Fluxoetine treatments were 0.3, 3, 30, and 300 ng/L of fluoxetine and a control with no

fluoxetine (Figure 2.1). A set of 5 tanks with no mussels were used to determine a
baseline for algae removed by the tank filtration systems during algal clearance trials. We
note that one of the no-mussel tanks malfunctioned after 20 days into the experiment and
was excluded from further analyses, reducing no-mussel tank replicates to 4.
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10.

Made measurements on day 47, 67, and 107

11.

Did not measure shell accretion rates

12.

Algal clearance rates were measured twice weekly, except in the event where the

Coulter counter machine was not working.
13.

Made measurments on day 47,67, and 107.

14.

Bioconcentraion of fluoxetine was transerferred to Dylan Dayrit as an undergraduate

thesis project under the direction of Dr. Elise Granek. Samples were preserved in the -80
freezer in the Granek/de Rivera Lab.
15.

Did not do a field component or use the pharmaceutical carbamazepine. Designed a

predator avoidance experiment using Fluoxetine instead.
16.

Statistical analyses were modified to the following procedures:

Fluoxetine exposure study: M. californianus:
For each sampling period, we averaged within-tank means for mussel growth,
GSI, CI, and algal clearance parameters. Normality and homogeneity of variances were
assessed through graphical inspection of the model residuals and respective ShapiroWilk’s and Levene’s tests, which indicated a need for data transformation. Algal
clearance data underwent a Box-Cox transformation (Box and Cox 1964) and mussel
growth and body condition data were log-transformed. Separate two-way ANOVAs were
run with treatment and sample date as fixed factors and tanks as an error term to account
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for non-independence between subsamples. Main effects were considered significant at
α=0.5. Post-hoc Tukey HSD tests were used for pairwise comparisons among treatment
and sample date means. All statistical analyses were performed using R statistical
platform (RStudio Version 3.2.2 (2015)).
Fluoxetine exposure study: H. oregonensis:
Ethograms from the trials were analyzed for crab behavior and predation risk. We
assessed differences in the proportion of active behaviors among H. oregonensis across
fluoxetine treatments, time period type (day and night), and trial type (predator/no
predator). To determine this proportion, we a priori divided active behaviors (i.e.,
walking, digging, foraging, and interactions between conspecifics) and non-active
behaviors (i.e., remaining still, buried, or just moving mandibles). We then tested whether
the probability that crabs would exhibit active behaviors varied among the three
fluoxetine treatment groups, time periods, and trial type, or a combination of these
variables, with a mixed-effect generalized linear model with a binomial error distribution
using the glmer function from lme4 package (Bates et al., 2015) in R Studio (R Core
Team, 2015). Our mixed-effect model included the crabs, trials, and tanks as random
effects to account for non-independence between samples, due to repeatedly observing
the same crabs over several trials and because of influences of behavior by individuals
within the same tank.
We used a similar modeling approach to assess whether the proportion of predator
avoidance behaviors varied by fluoxetine treatment and over time. Using data from
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predator trials only, we a priori determined predator avoidance behaviors as remaining
buried, still, or retreat under rock/elsewhere in tank and non-avoidance behaviors as
remaining active, foraging, or interacting without response to the predator. We used a
separate mixed-effects generalized linear model with a binomial error distribution to test
the probability that crabs would exhibit predator avoidance behaviors differently among
the three fluoxetine treatment groups and day/night time periods.
We were also interested in whether aggression among conspecifics varied across
fluoxetine treatments. We developed a third generalized mixed effects model with a
binomial error distribution that tested whether the proportion of aggressive acts between
H. oregonensis varied across the fluoxetine treatments, time of day, and trial type.
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